MCL - Act 345 of 2014
AN ACT to authorize access to and use of experimental treatments for patients with an advanced illness; to establish conditions for use of experimental treatment; to prohibit sanctions of health care providers solely for recommending or providing experimental treatment; to clarify duties of a health insurer with regard to experimental treatment authorized under this act; to prohibit certain actions by state officials, employees, and agents; and to restrict certain causes of action arising from experimental treatment.
History: 2014, Act 345, Imd. Eff. Oct. 17, 2014
| Document | Type | Description |
|---|---|---|
| Section 333.26451 | Section | Short title; definitions. |
| Section 333.26452 | Section | Availability of investigational drug, biological product, or device. |
| Section 333.26453 | Section | Coverage by health plan, third party administrator, or governmental agency; costs; new or additional services provided by hospital or facility. |
| Section 333.26454 | Section | Outstanding debt related to treatment or lack of insurance; liability of patient's heirs. |
| Section 333.26455 | Section | Licensing board or disciplinary committee; prohibitions; medicare certification entity; prohibitions. |
| Section 333.26456 | Section | Access to investigational drug, biological product, or device. |
| Section 333.26457 | Section | Private cause of action; participation in clinical trials. |